Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer

Lung cancer is the first leading cause of cancer deaths worldwide. Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer. Increasing evidence shows that long noncoding RNA (lncRNA) are capable of modulating tumor initiation, proliferation and metastasis. In the present study, we...

Full description

Bibliographic Details
Main Authors: Yujiao Xie, Yi Zhang, Lutao Du, Xiumei Jiang, Suzhen Yan, Weili Duan, Juan Li, Yao Zhan, Lili Wang, Shujun Zhang, Shuhai Li, Lishui Wang, Shuo Xu, Chuanxin Wang
Format: Article
Language:English
Published: Wiley 2018-05-01
Series:Molecular Oncology
Subjects:
diagnosis
long noncoding RNA
non‐small cell lung cancer
prognosis
serum
tumor biomarker
Online Access:https://doi.org/10.1002/1878-0261.12188

Internet

https://doi.org/10.1002/1878-0261.12188

Similar Items